Particularly, the ratio of CD4+ to CD8+ T cells is highly correlated to glioma grading, with higher grade gliomas (i.e., GBM) having large numbers of CD4+ T cells (>93%) compared to CD8+ T cells in the TME (211, 215). The gene discussed is CD8A; the disease is central nervous system cancer.